Lots of bite-size updates in this episode.Capitello-281: capivasertib + abiraterone (+ prednisone + ADT)Adjuvant Belzutifan + Pemroblizumab is FDA approvedDurvalumab approved with BCG for non-muscle invasive bladder cancer Insightful commentary: https://doi.org/10.1200/JCO-25-02670Talquetamab + Durvaluamb - a new safety signal?Learning Oncology Companion: https://www.kelleycpharmd.com/learning-oncology-companion-oncopharm